[go: up one dir, main page]

WO2006113050A4 - Reactifs de detection de phosphorylation de proteines dans la voie de signalisation de carcinome - Google Patents

Reactifs de detection de phosphorylation de proteines dans la voie de signalisation de carcinome Download PDF

Info

Publication number
WO2006113050A4
WO2006113050A4 PCT/US2006/010868 US2006010868W WO2006113050A4 WO 2006113050 A4 WO2006113050 A4 WO 2006113050A4 US 2006010868 W US2006010868 W US 2006010868W WO 2006113050 A4 WO2006113050 A4 WO 2006113050A4
Authority
WO
WIPO (PCT)
Prior art keywords
phosphorylated
antibody
column
tyrosine
protein
Prior art date
Application number
PCT/US2006/010868
Other languages
English (en)
Other versions
WO2006113050A8 (fr
WO2006113050A3 (fr
WO2006113050A2 (fr
Inventor
Ailan Guo
Klarisa Rikova
Albrecht Moritz
Yu Li
Charles Farnsworth
Kimberly Lee
Roberto Polakiewicz
Original Assignee
Cell Signaling Technology Inc
Ailan Guo
Klarisa Rikova
Albrecht Moritz
Yu Li
Charles Farnsworth
Kimberly Lee
Roberto Polakiewicz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Signaling Technology Inc, Ailan Guo, Klarisa Rikova, Albrecht Moritz, Yu Li, Charles Farnsworth, Kimberly Lee, Roberto Polakiewicz filed Critical Cell Signaling Technology Inc
Priority to EP06739581A priority Critical patent/EP1872134A4/fr
Publication of WO2006113050A2 publication Critical patent/WO2006113050A2/fr
Publication of WO2006113050A8 publication Critical patent/WO2006113050A8/fr
Publication of WO2006113050A3 publication Critical patent/WO2006113050A3/fr
Publication of WO2006113050A4 publication Critical patent/WO2006113050A4/fr
Priority to US12/985,879 priority patent/US20110105732A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne de nouveaux sites de phosphorylation identifiés dans des protéines de transduction de signal et dans des voies de tendance de carcinome humain et, fournit des anticorps spécifiques de sites de phosphorylation et des peptides étiquetés par des isotopes lourds (peptides AQUA) pour la détection et la quantification sélective de ces sites/protéines phosphorylés, ainsi que des techniques d'utilisation de ces réactifs à cet effet. Parmi les sites de phosphorylation identifiés, on distingue les sites survenant dans les types de protéine suivants : des protéines d'échafaudage/adaptateur, des protéines de cytosquelette, des protéine de signalisation GTP, des kinases, des protéines de métabolisme, des phosphatases/phospho-diesterases/protéases, des protéines réceptrices, des protéine de traitement ARN, des protéines de transcription, des protéines de traduction, des protéine transporteuses et des protéines d'ubiquitine, ainsi que d'autres types de protéines.
PCT/US2006/010868 2005-04-12 2006-03-24 Reactifs de detection de phosphorylation de proteines dans la voie de signalisation de carcinome WO2006113050A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP06739581A EP1872134A4 (fr) 2005-04-12 2006-03-24 Réactifs de détection de phosphorylation de protéines dans la voie de signalisation de carcinome
US12/985,879 US20110105732A1 (en) 2005-04-12 2011-01-06 Reagents for the Detection of Protein Phosphorylation in Carcinoma Signaling Pathways

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67044705P 2005-04-12 2005-04-12
US60/670,447 2005-04-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US67044705P Continuation 2005-04-12 2005-04-12

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/974,480 Continuation US20090099340A1 (en) 2005-04-12 2007-10-12 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways

Publications (4)

Publication Number Publication Date
WO2006113050A2 WO2006113050A2 (fr) 2006-10-26
WO2006113050A8 WO2006113050A8 (fr) 2007-12-27
WO2006113050A3 WO2006113050A3 (fr) 2008-12-24
WO2006113050A4 true WO2006113050A4 (fr) 2009-03-26

Family

ID=37115632

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/010868 WO2006113050A2 (fr) 2005-04-12 2006-03-24 Reactifs de detection de phosphorylation de proteines dans la voie de signalisation de carcinome

Country Status (2)

Country Link
EP (1) EP1872134A4 (fr)
WO (1) WO2006113050A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2307541B1 (fr) * 2008-06-23 2014-03-05 PerkinElmer Health Sciences, Inc. Substrats de kinases
CN111116734A (zh) * 2019-12-23 2020-05-08 维塔恩(广州)医药有限公司 肿瘤相关基因c-kit突变相关抗原短肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2117913C (fr) * 1992-04-10 2006-05-09 Richard J. Epstein Immunodetection de la phosphoproteine specifique de l'etat d'activation
AU2002307154A1 (en) * 2001-04-06 2002-10-21 Origene Technologies, Inc Prostate cancer expression profiles
US7335467B2 (en) * 2001-05-15 2008-02-26 Ludwig Institute For Cancer Research Breast cancer antigens

Also Published As

Publication number Publication date
EP1872134A2 (fr) 2008-01-02
WO2006113050A8 (fr) 2007-12-27
EP1872134A4 (fr) 2010-09-01
WO2006113050A3 (fr) 2008-12-24
WO2006113050A2 (fr) 2006-10-26

Similar Documents

Publication Publication Date Title
US7300753B2 (en) Immunoaffinity isolation of modified peptides from complex mixtures
Schürer et al. Aptamers that bind to the antibiotic moenomycin A
US20120149870A1 (en) Sequentially arranged streptavidin-binding modules as affinity tags
WO2007027867A3 (fr) Reactifs de detection de phosporylation proteinique dans des voies de signalisation de carcinome
US9631226B2 (en) Agents providing controls and standards for immunoprecipitation assays
WO2007027906A3 (fr) Reactifs de detection de phosphorylation proteinique dans des voies de signalisation de leucemie
WO2007027957A3 (fr) Reactifs pour la detection de la phosphorylation des proteines dans des processus de signalisation de la leucemie
CN101416061B (zh) 用于从复合蛋白质混合物检测和/或富集分析物蛋白质和/或分析物肽的方法
WO2006086111A3 (fr) Reactifs permettant de detecter une phosphorylation de proteines dans des voies de signalisation de leucemie
Okada et al. Peptide array X-linking (PAX): a new peptide-protein identification approach
CN114127281B (zh) 邻近相互作用分析
WO2008131315A3 (fr) Identification et procédé d'utilisation du domaine d'auto-association indépendante du ligand du récepteur il-17
WO2007127335A3 (fr) Réactifs pour la détection de la phosphorylation de protéines dans les voies de signalisation des kinases atm et atr
Yang et al. A multiple reaction monitoring (MRM) method to detect Bcr-Abl kinase activity in CML using a peptide biosensor
WO2006113050A4 (fr) Reactifs de detection de phosphorylation de proteines dans la voie de signalisation de carcinome
US9587013B2 (en) Immunoaffinity isolation of modified peptides from complex mixtures
TW202219062A (zh) 用於特性化mhci肽結合的測定及試劑
Chandra et al. Design of peptide ligands for affinity purification of human growth hormone
Arif et al. Experimental approaches for investigation of aminoacyl tRNA synthetase phosphorylation
WO2007133689A3 (fr) Réactifs pour la détection des chemins de signalisation de l'acétylation des protéines
WO2007133688A3 (fr) Réactifs pour la détection de la phosphorylation throsiniques dans els chemins de signalisation de l'ischémie cervicale
US20030113711A1 (en) Protein kinase peptide substrate determination using peptide libraries
WO1996005847A1 (fr) Procede de sequençage de proteines par classement d'epitopes et cartographie de sites de restriction de proteines
US20030134310A1 (en) Cellular kinase targets and inhibitors, and methods for their use
CA2454605C (fr) Isolation par immunoaffinite de peptides modifies a partir de melanges complexes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase in:

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006739581

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: RU